Validation of remote dielectric sensing (Reds) in monitoring adult patients affected by covid-19 pneumonia

8Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Remote dielectric sensing (ReDS) is a non-invasive electromagnetic wave technology which provides an accurate reading of lung fluid content, and it has been reported as a valid tool in monitoring heart failure patients. Considering that morphological alterations in COVID-19 include pulmonary edema, the purpose of the present study was to evaluate the reliability of ReDS technology in assessing the excess of lung fluid status in COVID-19 pneumonia, as compared to CT scans. In this pilot single center study, confirmed COVID-19 patients were enrolled on admission to an intermediate care unit. Measurements with the ReDS system and CT scans were performed on admission and at weeks 1 and 2. Eleven patients were recruited. The average change in ReDS was −3.1 ± 1.7 after one week (p = 0.001) and −4.6 ± 2.9 after two weeks (p = 0.006). A similar trend was seen in total CT score (−3.3 ± 2.1, p = 0.001). The level of agreement between ReDS and CT changes yielded a perfect result. Statistically significant changes were observed in lactate dehydrogenase, lymphocytes, and c-reactive protein over 2 weeks. This pilot study shows that ReDS can track changes in lung involvement according to the severity of COVID-19. Further studies to detect early clinical deterioration are needed.

Cite

CITATION STYLE

APA

Mei, F., Berardino, A. D. M., Bonifazi, M., Latini, L. L., Zuccatosta, L., & Gasparini, S. (2021). Validation of remote dielectric sensing (Reds) in monitoring adult patients affected by covid-19 pneumonia. Diagnostics, 11(6), NA. https://doi.org/10.3390/diagnostics11061003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free